MML Investors Services LLC trimmed its position in Steris PLC (NYSE:STE) by 9.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,610 shares of the medical equipment provider’s stock after selling 1,852 shares during the period. MML Investors Services LLC’s holdings in Steris were worth $1,882,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Squarepoint Ops LLC increased its stake in shares of Steris by 107.9% during the fourth quarter. Squarepoint Ops LLC now owns 8,973 shares of the medical equipment provider’s stock worth $959,000 after purchasing an additional 4,657 shares in the last quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in shares of Steris during the fourth quarter worth about $1,763,000. Bank of America Corp DE increased its stake in shares of Steris by 8.7% during the fourth quarter. Bank of America Corp DE now owns 803,434 shares of the medical equipment provider’s stock worth $85,848,000 after purchasing an additional 64,094 shares in the last quarter. Stone Ridge Asset Management LLC increased its stake in shares of Steris by 89.1% during the fourth quarter. Stone Ridge Asset Management LLC now owns 13,051 shares of the medical equipment provider’s stock worth $1,394,000 after purchasing an additional 6,150 shares in the last quarter. Finally, Thoroughbred Financial Services LLC purchased a new stake in shares of Steris during the fourth quarter worth about $267,000. Institutional investors own 88.04% of the company’s stock.
STE opened at $123.02 on Monday. The stock has a market cap of $10.41 billion, a P/E ratio of 29.64 and a beta of 1.07. Steris PLC has a twelve month low of $89.67 and a twelve month high of $125.49. The company has a current ratio of 2.56, a quick ratio of 1.99 and a debt-to-equity ratio of 0.40.
The company also recently announced a quarterly dividend, which was paid on Thursday, March 21st. Shareholders of record on Wednesday, February 27th were issued a $0.34 dividend. The ex-dividend date was Tuesday, February 26th. This represents a $1.36 annualized dividend and a yield of 1.11%. Steris’s payout ratio is 32.77%.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the business’s stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $125.00, for a total value of $6,250,000.00. Following the transaction, the chief executive officer now directly owns 98,895 shares in the company, valued at approximately $12,361,875. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Cynthia L. Feldmann sold 2,037 shares of the business’s stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $122.51, for a total transaction of $249,552.87. Following the completion of the transaction, the director now owns 10,700 shares in the company, valued at $1,310,857. The disclosure for this sale can be found here. Insiders sold a total of 60,396 shares of company stock worth $7,476,593 over the last quarter. 2.38% of the stock is currently owned by company insiders.
A number of equities analysts recently weighed in on STE shares. Zacks Investment Research lowered shares of Steris from a “hold” rating to a “sell” rating in a research report on Tuesday, March 19th. JMP Securities restated a “buy” rating and set a $135.00 price target on shares of Steris in a research report on Thursday, February 14th. Stephens restated a “buy” rating and set a $135.00 price target on shares of Steris in a research report on Thursday, February 14th. Finally, Sidoti boosted their price target on shares of Steris from $155.00 to $157.00 and gave the stock a “buy” rating in a research report on Thursday, December 6th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $138.20.
WARNING: “Steris PLC (STE) Holdings Trimmed by MML Investors Services LLC” was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://dakotafinancialnews.com/2019/03/25/steris-plc-ste-holdings-trimmed-by-mml-investors-services-llc.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: What is a good rate of return for a mutual fund?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.